Theravance Biopharma

TBPH NASDAQ
Overview Stats Financials News

Price & Volume

Stats

See more
52W Range $8.21-$11.98
Market Cap $442.8M
Shares Short 6M

Financials

See more
Revenue (12 Mos) $57.4M
Revenue Growth (YoY) 19.9%
Gross Profit (12 Mos) -$12M
Diluted EPS -$1

About

CEO Mr. Rick E. Winningham M.B.A.
CFO Mr. Aziz Sawaf C.F.A.
Address 901 Gateway Boulevard, South San Francisco, CA, United States, 94080
Sector Healthcare
Industry Biotechnology
Full-Time Employees 99